… time,” said Urrea, medical director and CEO of Psychiatric Care Systems and medical director of Behavioral Health Services at Monongahela Valley and Washington hospitals. “I was referring to the poor treatments we had years ago as …
Category: Hallucinations
Schizophrenia US Therapeutic and Drug Pipeline Review H2
PUNE, INDIA, January 17, 2017 / EINPresswire.com / — GET SAMPLE REPORT @ Summary Schizophrenia is a heterogeneous behavioral and cognitive syndrome involving chronic or recurrent psychosis. The disorder is characterized by several symptom domains including positive symptoms , negative symptoms , and cognitive deficits .
Market Study on Expected Growth for Schizophrenia Therapeutic by 2021
Schizophrenia is a severe mental disorder leading to disturbance of perception, thinking and social behavior. Patient suffering from this disease has problem in distinguishing between real and imaginary.